Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» AbbVie
AbbVie
Big pharma freshens up
Big pharma freshens up
EP Vantage
Merck
Bristol Myers Squibb
Astellas
Novo Nordisk
AbbVie
Sanofi
Flag link:
Series of JAK inhibitor delays may signal an upcoming FDA adcomm
Series of JAK inhibitor delays may signal an upcoming FDA adcomm
Endpoints
FDA
JAK inhibitors
AbbVie
Rinvoq
Pfizer
Xeljanz
Eli Lilly
olumiant
Flag link:
AbbVie presents applications to FDA and EMA for approval of SKYRIZI in psoriatic arthritis
AbbVie presents applications to FDA and EMA for approval of SKYRIZI in psoriatic arthritis
Pharmaceutical Business Review
AbbVie
Skyrizi
FDA
EMA
psoriatic arthritis
Flag link:
AbbVie's Rinvoq expansion hits a 2nd snag as FDA delays $2B atopic dermatitis ruling
AbbVie's Rinvoq expansion hits a 2nd snag as FDA delays $2B atopic dermatitis ruling
Fierce Pharma
AbbVie
Rinvoq
Humra
FDA
Flag link:
AbbVie Receives NDA for Atogepant, Aims to Stop Migraines in Their Tracks
AbbVie Receives NDA for Atogepant, Aims to Stop Migraines in Their Tracks
BioSpace
AbbVie
atogepant
migraines
FDA
Flag link:
AbbVie accuses rival of stealing blockbuster ‘trade secrets’ as clock ticks down on biosimilar assault
AbbVie accuses rival of stealing blockbuster ‘trade secrets’ as clock ticks down on biosimilar assault
Endpoints
AbbVie
Humira
trade secrets
Alvotech
Flag link:
13 leading drugmakers' top 3 drugs by revenue in 2020
13 leading drugmakers' top 3 drugs by revenue in 2020
Beckers Hospital Review
drug sales
revenue
AbbVie
Humira
Flag link:
AbbVie's approval delay raises further concerns about JAK drugs
AbbVie's approval delay raises further concerns about JAK drugs
BioPharma Dive
AbbVie
FDA
Rinvoq
rheumatoid arthritis
Flag link:
Horizon, Roche's Genentech, AbbVie and Neurocrine rank as top pharma places to work in annual poll
Horizon, Roche's Genentech, AbbVie and Neurocrine rank as top pharma places to work in annual poll
Fierce Pharma
Horizon Therapeutics
Roche
Genentech
AbbVie
Neurocrine
employee satisfaction
Flag link:
4 Pharma Stocks That Could Be Losers With the $1.9 Trillion Stimulus Package
4 Pharma Stocks That Could Be Losers With the $1.9 Trillion Stimulus Package
Motley Fool
stimulus
pharma stocks
Eli Lilly
Merck
Jazz Pharmaceuticals
AbbVie
Flag link:
AbbVie looks to shed Allergan's legacy women's health unit as it hunkers down for Humira biosim doomsday — report
AbbVie looks to shed Allergan's legacy women's health unit as it hunkers down for Humira biosim doomsday — report
Endpoints
AbbVie
Women's Health
Allergan
Humira
M&A
Flag link:
AbbVie to Fund Mitokinin's Parkinson Research with Option to Buy
AbbVie to Fund Mitokinin's Parkinson Research with Option to Buy
BioSpace
AbbVie
Parkinson's Disease
Mitokinin
Flag link:
AbbVie sells biologics plant to Pharmaron, fueling the China company's cell and gene therapy ambitions
AbbVie sells biologics plant to Pharmaron, fueling the China company's cell and gene therapy ambitions
Fierce Pharma
AbbVie
UK
biologics
drug manufacturing
Pharmaron
Flag link:
AbbVie puts an end to Botox trade secrets suit, imposes royalty, license deal on competitor Evolus
AbbVie puts an end to Botox trade secrets suit, imposes royalty, license deal on competitor Evolus
Endpoints
AbbVie
Botox
trade secrets
Evolus
Flag link:
AbbVie adds to the Botox war chest with a 12th FDA approval — but competition is fast approaching
AbbVie adds to the Botox war chest with a 12th FDA approval — but competition is fast approaching
Endpoints
AbbVie
Botox
bladder muscle overactivity
Flag link:
After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact
After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact
Fierce Biotech
AbbVie
Editas Medicine
CRISPR
Caribou Biosciences
gene editing
Flag link:
AbbVie's immunology newbies Skyrizi and Rinvoq pick up the slack from declining Humira, but safety questions dog execs
AbbVie's immunology newbies Skyrizi and Rinvoq pick up the slack from declining Humira, but safety questions dog execs
Fierce Pharma
AbbVie
FDA
Skyrizi
Rinvoq
Humira
earnings
Flag link:
AZ says Calquence is a safer drug than Imbruvica
AZ says Calquence is a safer drug than Imbruvica
Pharmaforum
AstraZeneca
Calquence
Imbruvica
JNJ
AbbVie
CLL
Flag link:
Pharma TV ad spenders blow up December with spendiest month of 2020
Pharma TV ad spenders blow up December with spendiest month of 2020
Fierce Pharma
television ads
AbbVie
Humira
Novo Nordisk
DTC ads
Flag link:
AbbVie eyes Humira matching move into psoriatic arthritis for immunology follow-up Skyrizi
AbbVie eyes Humira matching move into psoriatic arthritis for immunology follow-up Skyrizi
Endpoints
AbbVie
Humira
psoriatic arthritis
Skyrizi
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »